Analysis on Impact of COVID-19- Global Prosthetic Heart Valves Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio | Business

Analysis on Impact of COVID-19- Global Prosthetic Heart Valves Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio | Business

LONDON–(BUSINESS WIRE)–Sep 8, 2020–

The global prosthetic heart valves market size is expected to grow by USD 3.76 billion as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 9%. Request Free Sample Report on COVID-19 Impacts

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200907005272/en/

Technavio has announced its latest market research report titled Global Prosthetic Heart Valves Market 2020-2024 (Graphic: Business Wire)

Read the 120-page report with TOC on “Prosthetic Heart Valves Market Analysis Report by Product (transcatheter heart valves, tissue heart valves, and mechanical heart valves) and Geography (Europe, North America, APAC, and ROW), and the Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/prosthetic-heart-valves-market-industry-analysis

The market is driven by the growing prevalence of heart-related disorders. In addition, the rising demand for MI procedures is anticipated to boost the growth of the Prosthetic Heart Valves Market.

The growing prevalence of heart-related disorders, such as cardio valvular diseases, and valvular and heart failure is expected to drive the growth of the prosthetic heart valves market. In addition, prosthetic valve thrombosis, mechanical hemolytic anemia, prosthetic valve endocarditis, and thromboembolism are some of the other complications indirectly contributing to market growth. Further, stroke, rhythm disorder, congenital heart disease, subclinical atherosclerosis, heart failure, and peripheral arterial disease are other major clinical complications that have increased the demand for cardiac prosthetic devices globally.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Prosthetic Heart Valves Companies:

Abbott Laboratories

Abbott Laboratories has business operations under four segments: established pharmaceutical products, nutritional products, diagnostic products, and medical devices. The company’s key offerings include MITRACLIP TRANSCATHETER MITRAL VALVE REPAIR, which is specially designed to treat high-surgical-risk patients with significant degenerative mitral regurgitation.

Boston Scientific Corp.

Boston Scientific Corp. operates its business through four segments: MedSurg, rhythm and neuro, cardiovascular, and specialty pharmaceuticals. The company offers LOTUS Edge Valve SystemIt, which is a next-generation controlled mechanical expansion TAVR technology, designed to provide unmatched freedom from PVL, ensure precise delivery and deployment, and deliver predictable results.

Colibri Heart Valve LLC

Colibri Heart Valve LLC generates revenue through the development of disruptive, ready-to-use, structural heart technologies. The company offers Transcatheter Aortic Valve Implantation System, which is a low profile transcatheter aortic heart valve that uses dry tissue technology to allow for a pre-mounted, pre-crimped, and pre-loaded heart valve.

CryoLife Inc.

CryoLife Inc. has business operations under two segments: medical devices and preservation services. The company offers On-X Prosthetic heart valve, which is an aortic mechanical heart valve which can be used with less blood thinner.

Edwards Lifesciences Corp.

Edwards Lifesciences Corp. operates its business through various geographical segments such as United States, Europe, Japan, and ROW. The company offers Edwards SAPIEN 3 transcatheter heart valve, which is used for indicating relief of aortic stenosis in patients with symptomatic heart disease caused due to severe native calcific aortic stenosis.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Prosthetic Heart Valves Market Product Outlook (Revenue, USD bn, 2020-2024)

  • Transcatheter heart valves – size and forecast 2019-2024
  • Tissue heart valves – size and forecast 2019-2024
  • Mechanical heart valves – size and forecast 2019-2024

Prosthetic Heart Valves Market Regional Outlook (Revenue, USD bn, 2020-2024)

  • Europe – size and forecast 2019-2024
  • North America – size and forecast 2019-2024
  • APAC – size and forecast 2019-2024
  • ROW – size and forecast 2019-2024

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200907005272/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:www.technavio.com/

KEYWORD:

INDUSTRY KEYWORD: HEALTH SURGERY CARDIOLOGY MEDICAL DEVICES

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 09/08/2020 12:45 AM/DISC: 09/08/2020 12:45 AM

http://www.businesswire.com/news/home/20200907005272/en

Source Article